1. Home
  2. CADL vs EVGO Comparison

CADL vs EVGO Comparison

Compare CADL & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • EVGO
  • Stock Information
  • Founded
  • CADL 1999
  • EVGO 2010
  • Country
  • CADL United States
  • EVGO United States
  • Employees
  • CADL N/A
  • EVGO N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • EVGO Other Specialty Stores
  • Sector
  • CADL Health Care
  • EVGO Consumer Discretionary
  • Exchange
  • CADL Nasdaq
  • EVGO Nasdaq
  • Market Cap
  • CADL 234.8M
  • EVGO 376.5M
  • IPO Year
  • CADL 2021
  • EVGO N/A
  • Fundamental
  • Price
  • CADL $4.76
  • EVGO $3.83
  • Analyst Decision
  • CADL Strong Buy
  • EVGO Strong Buy
  • Analyst Count
  • CADL 4
  • EVGO 10
  • Target Price
  • CADL $21.00
  • EVGO $5.78
  • AVG Volume (30 Days)
  • CADL 864.6K
  • EVGO 3.9M
  • Earning Date
  • CADL 05-13-2025
  • EVGO 05-06-2025
  • Dividend Yield
  • CADL N/A
  • EVGO N/A
  • EPS Growth
  • CADL N/A
  • EVGO N/A
  • EPS
  • CADL N/A
  • EVGO N/A
  • Revenue
  • CADL N/A
  • EVGO $276,954,000.00
  • Revenue This Year
  • CADL N/A
  • EVGO $39.82
  • Revenue Next Year
  • CADL N/A
  • EVGO $32.12
  • P/E Ratio
  • CADL N/A
  • EVGO N/A
  • Revenue Growth
  • CADL N/A
  • EVGO 45.15
  • 52 Week Low
  • CADL $3.79
  • EVGO $1.78
  • 52 Week High
  • CADL $14.60
  • EVGO $9.07
  • Technical
  • Relative Strength Index (RSI)
  • CADL 41.42
  • EVGO 79.08
  • Support Level
  • CADL $4.80
  • EVGO $2.66
  • Resistance Level
  • CADL $5.34
  • EVGO $4.17
  • Average True Range (ATR)
  • CADL 0.33
  • EVGO 0.23
  • MACD
  • CADL 0.10
  • EVGO 0.13
  • Stochastic Oscillator
  • CADL 42.09
  • EVGO 81.13

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: